Influence of mucoidy on antibody coating of Pseudomonas aeruginosa.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 109548)

Published in J Infect Dis on March 01, 1979

Authors

T J Marrie, G K Harding, A R Ronald, J Dikkema, J Lam, S Hoban, J W Costerton

Articles by these authors

A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87

The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science (1998) 19.92

Bacterial biofilms in nature and disease. Annu Rev Microbiol (1987) 16.14

Antibiotic resistance of bacteria in biofilms. Lancet (2001) 12.62

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet (1989) 11.39

Biofilms as complex differentiated communities. Annu Rev Microbiol (2002) 9.31

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08

How bacteria stick. Sci Am (1978) 9.00

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41

Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev (1974) 7.42

Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother (1985) 7.31

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05

The bacterial glycocalyx in nature and disease. Annu Rev Microbiol (1981) 6.98

Survival strategies of infectious biofilms. Trends Microbiol (2005) 6.73

Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun (1980) 6.61

Syntrophomonas wolfei gen. nov. sp. nov., an Anaerobic, Syntrophic, Fatty Acid-Oxidizing Bacterium. Appl Environ Microbiol (1981) 6.15

A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med (1966) 5.80

Optical sectioning of microbial biofilms. J Bacteriol (1991) 5.60

Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10

Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med (2001) 5.08

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68

Male circumcision: assessment of health benefits and risks. Sex Transm Infect (1998) 4.59

Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med (1988) 4.55

Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest (2000) 4.54

Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol (1978) 4.20

Diagnosis of Q fever. J Clin Microbiol (1998) 4.16

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis (2000) 4.01

Cultivation of the bacillus of Whipple's disease. N Engl J Med (2000) 3.97

Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol (1984) 3.88

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68

Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol (1990) 3.63

Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med (1996) 3.61

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis (1994) 3.59

The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS (1989) 3.48

The role of bacterial surface structures in pathogenesis. Crit Rev Microbiol (1981) 3.42

Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res (1991) 3.41

Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother (1978) 3.23

Release of alkaline phosphatase from cells of Pseudomonas aeruginosa by manipulation of cation concentration and of pH. J Bacteriol (1970) 3.19

Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody. J Bacteriol (1979) 3.03

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03

Cell envelope morphology of rumen bacteria. J Bacteriol (1974) 3.00

Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00

Layered structure of bacterial aggregates produced in an upflow anaerobic sludge bed and filter reactor. Appl Environ Microbiol (1990) 2.97

Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis (1981) 2.89

Ultrastructure and adhesion properties of Ruminococcus albus. J Bacteriol (1975) 2.88

Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol (1977) 2.70

Microbiology of a northern river: bacterial distribution and relationship to suspended sediment and organic carbon. Can J Microbiol (1979) 2.68

Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother (1992) 2.61

The role of the bacterial cell envelope in antibiotic resistance. J Antimicrob Chemother (1975) 2.59

Observations of fouling biofilm formation. Can J Microbiol (1981) 2.56

Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother (1990) 2.51

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.50

A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation (1982) 2.43

Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother (1992) 2.43

Determination of the hemin requirement of Haemophilus ducreyi: evaluation of the porphyrin test and media used in the satellite growth test. J Clin Microbiol (1978) 2.37

Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) (2001) 2.37

The release of alkaline phosphatase and of lipopolysaccharide during the growth of rough and smooth strains of Salmonella typhimurium. Can J Microbiol (1973) 2.35

Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet (1988) 2.33

Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun (2002) 2.32

Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29

Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am (1985) 2.27

Interactions of alkaline phosphatase and the cell wall of Pseudomonas aeruginosa. J Bacteriol (1971) 2.23

Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun (1985) 2.23

Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22

Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21

Bacterial fouling in a model core system. Appl Environ Microbiol (1985) 2.20

Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med (1988) 2.20

Bacteriuria in elderly institutionalized men. N Engl J Med (1983) 2.20

Separation and localization of cell wall layers of a gram-negative bacterium. J Bacteriol (1970) 2.16

Nutrition and metabolism of marine bacteria. XVI. Formation of protoplasts, spheroplasts, and related forms from a gram-negative marine bacterium. J Bacteriol (1967) 2.15

Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol (1983) 2.13

Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis (1987) 2.10

Permeability of lipopolysaccharide-deficient (rough) mutants of Salmonella typhimurium to antibiotics, lysozyme, and other agents. Can J Microbiol (1974) 2.10

Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother (1991) 2.09

Electron microscopic study of an infected Foley catheter. Can J Surg (1985) 2.09

Growth and detachment of cell clusters from mature mixed-species biofilms. Appl Environ Microbiol (2001) 2.08

Pseudomonas aeruginosa outer membrane: peptidoglycan-associated proteins. J Bacteriol (1981) 2.06

The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05

Strategies for prophylaxis against prosthetic valve endocarditis: a review article. J Heart Valve Dis (1998) 2.03

Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) (1966) 1.99

Electrical enhancement of biocide efficacy against Pseudomonas aeruginosa biofilms. Appl Environ Microbiol (1992) 1.99

Bacteriuria localization and response to single-dose therapy in women. JAMA (1976) 1.98

The biofilm glycocalyx as a resistance factor. J Antimicrob Chemother (1990) 1.98

Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev (1990) 1.98

Ultrastructure of Butyrivibrio fibrisolvens: a gram-positive bacterium. J Bacteriol (1977) 1.96

Adhesion of bacteria to epithelial cell surfaces within the reticulo-rumen of cattle. Appl Environ Microbiol (1978) 1.95

Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis (1983) 1.92

Staphylococcus saprophyticus as a cause of urinary tract infections. J Clin Microbiol (1982) 1.91

The postantibiotic effect: a review of in vitro and in vivo data. DICP (1991) 1.91

Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl Environ Microbiol (2002) 1.91

Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis (1985) 1.91

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother (2000) 1.89

Prevention and control of bacterial infections associated with medical devices. ASAIO J (1993) 1.88